PHIO PHARMACEUTICALS CORP (PHIO) Stock Income Statement
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 7.05M | 7.39M | 10.87M | 11.46M | 13.51M | |||
| Research and Development | 3.38M | N/A | 6.33M | 7.01M | 8.89M | |||
| Selling, General, and Administrative Expenses | 3.67M | 3.74M | 4.37M | 4.45M | 4.63M | |||
| Operating Income | -7.05M | -7.39M | -10.87M | -11.46M | -13.51M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | -10.00K | |||
| Other Income/Expense | -69.00K | 10.00K | 0.00 | -20.00K | N/A | |||
| Non Recurring Items | N/A | 0.00 | -130.00K | N/A | 230.00K | |||
| Income Before Taxes | -6.77M | -7.15M | -11.00M | -11.48M | -13.29M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -6.77M | -7.15M | -11.00M | -11.48M | -13.29M | |||
| EBITDA | N/A | -7.36M | -10.69M | -11.39M | -13.43M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -7.00 | -9.05 | -47.82 | -10.07 | -12.43 | |||
| Non GAAP EPS | N/A | -6.48 | N/A | -90.72 | N/A | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD